跳至主要內容

新聞與行事曆

新聞: 截至 2026-10-07
這些標記是什麼意思

重要性是模型對已發布報導給出的 1–5 分,不是對市場的預測。

已排定事件列上的影響是公司顯著度層級(高/中由圖譜中心度與規模判定;低僅用於人工整理的次要事件),不是對波動幅度的預測。

標記為已確認的財報日期,是 Yahoo Finance 認定由公司確認的;預估表示尚未公布。未加標記的列沒有可查的出處記錄。

經濟數據發布屬於總體經濟、不歸屬任何產業,因此在任何檢視下都會保留。沒有數值的發布表示尚未公布,頁面會直說,而不是顯示為零。

涵蓋被追蹤公司的即將到來的事件;已過去的事件會歸檔,並在可得時補上結果——這些結果都經人工整理並附引用,絕不杜撰。沒有結果的歷史列會顯示「結果待定」。

閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數,或指數基金必須買進的股數,以佔流通股的比例表示——依招股說明書或指數編製方法讀出,兩個數字都在該列註明出處。它陳述的是機制,不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估,直到公司自己說明為止。

未來

已排定 · 今天與明天 · 行事曆更新於 2026-10-07

10月7日週三 · 今天

10月8日週四

過往

已發布 · 最新在前

8月28日週五

合作

10:17
GlobeNewswire

Teva announces proposed acquisition of a novel neuroscience product

Teva announced a proposed acquisition of a novel neuroscience product under its Pivot to Growth strategy. A same-day release from BioXcel Therapeutics announcing an asset sale agreement with Teva Pharmaceuticals identifies the counterparty. Deal terms are not stated in the headline and are not reproduced here.

大盤 開啟原文 ↗

產品

07:00
GlobeNewswire

Roche's Vabysmo shows sustained two-year results in difficult-to-treat nAMD

Roche reported that Vabysmo demonstrated sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration. This is follow-up data on an already-approved product, so it is graded as incremental.

大盤 開啟原文 ↗

8月27日週四

財報

15:43
Yahoo Finance

Canadian Solar Q2 Loss Wider Than Estimates, Revenues Fall Y/Y

Canadian Solar reported a Q2 2026 loss of $1.40 per share versus a consensus estimate of a $1.01 loss and a year-ago loss of $0.08. Revenue of $1.21 billion topped the $1.17 billion consensus but fell 28.7% from $1.69 billion a year earlier, and solar modules recognized as revenue totaled 3.1 gigawatts, down 25% year over year. The company guided Q3 revenue to $1.30-$1.50 billion with gross margin of 13.5%-15.5%, below the $1.65 billion Q3 consensus cited in the article.

大盤 開啟原文 ↗

產品

15:00
Yahoo Finance

RTX's Raytheon completes $50 million expansion of Mississippi manufacturing facility

RTX's Raytheon business completed a $50 million, 17,000 square-foot expansion of its Forest, Mississippi plant, bringing the site to 445,000 square feet of manufacturing space. The facility builds electronic warfare and radar systems including Next Generation Jammer Mid-Band pods for the U.S. Navy and the Australian government, and the expansion is expected to add 100 high-skill positions by 2028.

大盤 開啟原文 ↗

合作

12:50
GlobeNewswire

argenx completes acquisition of Forte Biosciences

argenx announced it has completed its acquisition of Forte Biosciences, Inc. Forte is not in this universe, so it is not listed as a counterparty. Consideration is not stated in the headline and is not reproduced here.

大盤 開啟原文 ↗

原始消息流

所有到達的消息 · 7 天